Rovensa acquired by BRIDGEPOINT
Context
The European private equity firm Bridgepoint finalizes the acquisition of the Portuguese agrochemical specialist Sapec Agro (now Rovensa) in a primary buyout transaction valuing the target at an enterprise value of €300–700M. Executed in late 2016 and officially closed during the 2017 fiscal year, this definitive ownership transfer incorporates the Iberian crop protection leader into the acquirer's diversified industrial portfolio. The strategic rationale underpinning this institutional capital deployment centers on aggressively scaling the target's international footprint and consolidating its prominent market position within the rapidly expanding biological agricultural solutions sector. By injecting fresh financial resources and institutional governance frameworks, the incoming majority shareholder aims to accelerate the company's research-led pipeline and execute a rigorous external growth strategy to penetrate new geographies. The post-acquisition roadmap specifically allocates significant capital reserves to fund strategic add-on acquisitions, enabling the target to internalize complementary bio-nutrition technologies and expand its European manufacturing capacity. This targeted buy-and-build consolidation framework is designed to actively transition the company from a regional market leader into a globally diversified biosolutions platform, perfectly positioned to deliver bespoke agricultural inputs to a highly regulated and environmentally conscious international farming base. The transaction execution mobilized specialized financial and legal advisory syndicates to conduct comprehensive commercial and operational due diligence prior to final signature. Following the successful capital restructuring, the target entity was comprehensively rebranded to better reflect its renewed global ambitions and specialized focus on sustainable agronomic paradigms under the exclusive strategic backing of its new private equity owner. This structural shift effectively provides the executive management team with the autonomous operational agility and robust financial backing required to navigate the increasingly complex regulatory landscapes governing international agrochemical distribution and secure long-term global market share.
-> Deep-dive in Industry & Manufacturing market trends
Target
Rovensa operates as a specialized provider of agricultural biosolutions and biocontrol technologies headquartered in Portugal. Founded in 1926, the independent industrial company engineers and formulates sustainable crop nutrition and protection products explicitly designed to enhance agricultural yields while minimizing ecological impacts. The operational architecture is rigidly organized into three distinct manufacturing and research divisions: BioNutrition, which supplies essential nutrients for healthy crop development; Crop Protection, which focuses on eliminating or preventing biological threats; and BioControl, which utilizes biological inputs such as plant extracts and micro-organisms. By deploying these specialized biorational and biostimulant portfolios, the enterprise assists farmers in addressing global food security challenges, combating agriculture's wider contribution to climate change, and cultivating healthy food. The organization maintains a vast international distribution footprint, ensuring its proprietary agricultural solutions are actively sold across more than 70 countries worldwide. Relying on robust, centralized research and development capabilities, the firm continuously innovates within high-growth market niches, providing critical technologies that mitigate natural resource degradation and biodiversity loss.
Ent. Value
€300–700M
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Rovensa
Other operations with Rovensa
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2020 | PARTNERS GROUP | Rovensa | PORTUGAL | Specialty Chemicals |
Similar deals in Chemicals & Materials
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2017 | LONE STAR FUNDS | ESMALGLASS | SPAIN | Specialty Chemicals |
| 02/2017 | WISE EQUITY | TAPÌ | ITALY | Packaging & Containers |
| 12/2016 | CHEQUERS | ALKERN | FRANCE | Construction Materials |
| 12/2016 | IMERYS | KERNEOS | FRANCE | Construction Materials |
| 11/2016 | ARDIAN | HYPRED | FRANCE | Specialty Chemicals |
| 10/2016 | MANALI PETROCHEMICALS | NOTEDOME | UNITED KINGDOM | Plastics |
| 07/2016 | IDEX CORPORATION | FTL SEALS TECHNOLOGY | UNITED KINGDOM | Plastics |
| 04/2016 | EURAZEO / MERIEUX EQUITY PARTNERS | NOVACAP | FRANCE | Specialty Chemicals |
| 03/2016 | SILVERFLEET | COVENTYA | FRANCE | Specialty Chemicals |
| 01/2016 | ALLIANCE ETIQUETTES | IMPRIMERIE MAUMY | FRANCE | Labels & Adhesives |
Other operations with BRIDGEPOINT
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2026 | BRIDGEPOINT | VIPR Solutions | UNITED KINGDOM | Data, Analytics & AI |
| 09/2026 | BRIDGEPOINT | ALTANO | GERMANY | Vet Clinics |
| 07/2026 | BRIDGEPOINT | GBA GROUP | GERMANY | TIC (Testing, Inspection, Certification) |
| 07/2026 | BRIDGEPOINT | SKELLO | FRANCE | ERP, HR & Finance |
| 06/2026 | BRIDGEPOINT | OBAGI MEDICAL | UNITED STATES | Generics / Labs |
| 06/2026 | BRIDGEPOINT | Kayne Anderson Real Estate | UNITED STATES | Wealth & Asset Management |
| 02/2026 | BRIDGEPOINT / POLARIS PRIVATE EQUITY | PDSVISION GROUP | SWEDEN | Consulting & Integration |
| 01/2026 | BRIDGEPOINT | INTERPATH | UNITED KINGDOM | Accounting & Audit |
| 07/2025 | BRIDGEPOINT | MYDENTIST | UNITED KINGDOM | Dental Centers |
| 07/2025 | BRIDGEPOINT | HANSEATIC BROKING CENTER (HBC) | GERMANY | Brokerage |
REFERENCES
Valuation range: EV €300–700M
Revenue range: €100–200M
EBITDA range: €25–50M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Rovensa by BRIDGEPOINT are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: rovensa
Acquirer: bridgepoint